Back to top

Image: Bigstock

Top Ranked Growth Stocks to Buy for January 30th

Read MoreHide Full Article

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, January 30th:

SYNNEX Corporation (SNX - Free Report) : This is a technology company, which provides business process services carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.8% over the last 60 days.

SYNNEX has a PEG ratio of 0.97 compared with 4.04 for the industry. The company possesses a Growth Score of A.

Focus Financial Partners (FOCS - Free Report) : This company which provides wealth management services to primarily high net worth individuals and families carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.3% over the last 60 days.

Focus Financial Partners has a PEG ratio of 0.45, compared with 1.26 for the industry. The company possesses a Growth Score of A.

TopBuild Corp. (BLD - Free Report) : This company that engages in the installation and distribution of insulation and other building products carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.3% over the last 60 days.

TopBuild has a PEG ratio of 0.67, compared with 1.42 for the industry. The company possesses a Growth Score of A.

TopBuild Corp. PEG Ratio (TTM)

TopBuild Corp. PEG Ratio (TTM)

TopBuild Corp. peg-ratio-ttm | TopBuild Corp. Quote

Berry Global Group, Inc. (BERY - Free Report) : This company that manufactures and supplies non-woven, flexible, and rigid products which carries a Zacks Rank #2, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.3% over the last 60 days.

Berry Global has a PEG ratio of 0.90, compared with 1.85 for the industry. The company possesses a Growth Score of B.

See the full list of top ranked stocks here.

Learn more about the Growth score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Published in